As part of its efforts to address the rising demand for robust healthcare logistics services, FedEx has expanded its state-of-the-art Life Science Center in Gimpo, Gyeonggi-do, South Korea.
Covering 2,288m2 , the new facility is almost triple the size of its predecessor and includes five temperature-controlled areas for temperatures ranging from -150°C to +25°C, which are monitored 24/7 to ensure continuous compliance with pharmaceutical cold chain requirements.
The facility is also Korea Good Supply Practice-certified (KGSP), in accordance with market-specific quality and regulatory requirements for the healthcare industry, and is equipped to support both domestic and international transportation needs.
“Asia-Pacific’s healthcare sector is evolving at an unprecedented pace, driven by demographic shifts, infrastructure investments and rapid tech advancements,” said Kawal Preet, president, Asia-Pacific at FedEx. “At FedEx, we are leveraging our decades of healthcare expertise, extensive global network and differentiated solutions to propel this growth. Through strategic investments in cutting-edge facilities and AI-driven smart logistics, we are reshaping healthcare supply chains and enabling the future of life sciences research and business innovation across the region.”